Courage Capital Management LLC Crispr Therapeutics Ag Transaction History

Courage Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$53.19 - $79.24 $162,229 - $241,681	-3,050 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$79.67 - $173.23 $59,752 - $129,922	-750 Reduced 19.74%	3,050 $467,000
Q2 2020 Aug 14, 2020	BUY	$38.5 - $76.05 $146,300 - $288,990	3,800 New	3,800 $279,000
Q1 2020 May 15, 2020	SELL	$33.68 - $62.53 $127,984 - $237,614	-3,800 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$36.68 - $73.13 $139,384 - $277,894	3,800 New	3,800 $231,000
Q3 2018 Nov 14, 2018	SELL	$44.35 - $65.71 $319,320 - $473,111	-7,200 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$42.62 - $73.59 $38,358 - $66,231	-900 Reduced 11.11%	7,200 $423,000
Q4 2017 Feb 14, 2018	BUY	$16.95 - $23.48 $137,295 - $190,188	8,100	8,100 $190,000

485

64.1M

1.64M

1.93M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.63B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Courage Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Courage Capital Management LLC with notifications on news.